Finland· FI-REL-REL55568
Ultifend ND IBD
A avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus product containing recombinant turkey herpesvirus, live (ndv and vp2 of ibdv), registered in Finland by Ceva-Phylaxia Co. Ltd.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Recombinant turkey herpesvirus, live (ndv and vp2 of ibdv) is registered in 2 of 19 countries.
Countries holding a registration under ATC QI01AD16 (avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Recombinant turkey herpesvirus, live (ndv and vp2 of ibdv) · ATC QI01AD16
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Recombinant turkey herpesvirus, live (NDV and VP2 of IBDV)
- Manufacturer
- Ceva-Phylaxia Co. Ltd.
- Country
- Finland (FI)
- ATC code
- QI01AD16
- ATC class
- avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QI01AD16
Avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5715747b-6356-4c49-b7bb-df2896d8e644 GET /v1/drugs/5715747b-6356-4c49-b7bb-df2896d8e644?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokonsentraatti ja liuotin, suspensiota varten",
"route": "Ihon alle",
"ddd_unit": null,
"strength": null,
"atc_label": "avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/2/21/272/001-003",
"fimea_rel_id": "REL55568",
"authorised_at": "2021-04-20"
}See everything about recombinant turkey herpesvirus, live (ndv and vp2 of ibdv).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.